Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Six-planet solar system found
Henry Kissinger dies
Disney CEO to step down
Tony-winning actress dies
‘I don’t want to die’
Quits 'I'm A Celebrity'
Sued for Binance promotion
Reveals ectopic pregnancy
Split after welcoming baby
Nixon joins hunger strike
‘It was a perfect day’
Kelce’s nickname for Swift
SDSU hires Sean Lewis
Acquiring Rover for $2.3B
'Friends' viewership rockets
'SNL' sets last 2023 hosts
Ending w/ season 5 on CBS
Threatened with extinction
Divorce after 7 years
In talks to merge with Humana
Hits back at advertisers
RU mulls 'loyalty pledge’
'Ted' series trailer
Guide to Spotify Wrapped
Trims annual sales forecast
2-year deal with Reds
1st trip to Shanghai in 3 yrs
Honors Matthew Perry
Panthers sign Jackson
Worker dragged under train
Finland closes RU border
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
899 results
Commonwealth Fund
11h
How Drug Price Reforms in the Inflation Reduction Act Could Impact States
Legislative solutions to the prescription drug price issue were slow to materialize until the Inflation Reduction Act changed ...
Health Affairs
1d
Arriving At A Fair Price In The Medicare Drug Price Negotiation Program: Considerations From Other Countries
The drug pricing paradigms of Canada, France, and Germany offer lessons for the United States on how to arrive at a “fair ...
JD Supra3d
Are Drugmakers Gaming the Patent System?
We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...
STAT1d
White House official dings Bristol Myers Squibb for fighting off generic competition
WASHINGTON — A top White House official on Tuesday delivered a pointed attack at a drugmaker fighting the administration’s ...
5d
Novartis Urges Court to Hand It Quick Win in Drug Price Battle
Medicare’s drug price negotiation program violates the Constitution and must be struck down, Novartis Pharmaceuticals said in ...
Fierce Healthcare21d
CMS wants feedback on how Medicare drug negotiations should evolve. Researchers, advocates, drugmakers all have notes
In terms of therapeutic breakthroughs, Isasi suggested that the drug price negotiation program’s current structure is an effective deterrent from drugmakers’ low-impact profit chasing. “In ...
Fierce Healthcare23d
Trump, Biden HHS chiefs clash over impact of Medicare drug price negotiations
Two health secretaries from the Trump and Biden administrations agree that bringing down high drug costs is a critical priority to make healthcare more affordable for patients. But they have far ...
12don MSN
The inescapable ad campaign for a wonky drug policy debate
A seven-figure, yearlong PhRMA ad campaign has taken a very wonky policy debate mainstream — and it's made a longtime actor a ...
HealthLeaders Media21d
Patient Advocates Rap 'Greedy' PhRMA IRA Lawsuits
As consumers struggle with soaring drug prices, AstraZeneca Q3 profits doubled to $1.37 billion. The pharmaceutical industry is enjoying record profits while simultaneously pursuing lawsuits ...
FiercePharma22d
With Amgen's biosim on the scene, J&J's Stelara looks poised to sidestep Medicare negotiations: HHS
There might just be a silver lining for Johnson & Johnson in the FDA's recent approval of Amgen’s Stelara biosimilar. That’s because the coming entry of a cheaper copycat presents J&J with an ...
Wausau Pilot and Review
2d
When will Wisconsinites see relief from high drug prices? A health insurance broker weighs in
Wisconsin Public Radio This year, Medicare will start negotiating lower prescription drug prices. But one Wisconsin insurance broker ...
Politico22d
A crackdown on Medicare Advantage plan sales
TAMING HEALTH CARE ‘MIDDLEMEN’ — The Biden administration wants to cap the amount insurers can pay Medicare Advantage brokers and agents per enrollee, POLITICO’s Robert King reports.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices